T. Macfarlane, Orofacial pain : just another chronic pain ? Results from a population-based survey, Pain, vol.99, pp.453-458, 2002.

G. Madland, T. Newton-john, and C. Feinmann, Chronic idiopathic orofacial pain: I: What is the evidence base?, Br Dent J, vol.191, issue.1, pp.22-26, 2001.

S. Love and H. Coakham, Trigeminal neuralgia : pathology and pathogenesis, vol.124, pp.2347-60, 2001.

G. C. Manzoni and P. Torelli, Epidemiology of typical and atypical craniofacial neuralgias, Neurol Sci, vol.26, issue.2, pp.65-72, 2005.

A. Woda and P. Pionchon, Orofacial idiopathic pain: clinical signs, causes and mechanisms, Rev Neurol, vol.157, issue.3, pp.265-83, 2001.

R. L. Campbell, K. W. Parks, and R. N. Dodds, Chronic facial pain associated with endodontic therapy. Oral Surg Oral Med Oral Pathol, vol.69, pp.287-90, 1990.

J. P. Goulet, G. J. Lavigne, and J. P. Lund, Jaw pain prevalence among Frenchspeaking Canadians in Quebec and related symptoms of temporomandibular disorders, J Dent Res, vol.74, issue.11, pp.1738-1782, 1995.

H. A. Gremillion, The prevalence and etiology of temporomandibular disorders and orofacial pain, Tex Dent J, vol.117, issue.7, pp.30-39, 2000.

M. Navez, Primary and atypical facial pain: diagnosis and treatment, Rev Med Interne, vol.26, issue.9, pp.703-719, 2005.

A. Woda, Pain in the trigeminal system: from orofacial nociception to neural network modeling, J Dent Res, vol.82, issue.10, pp.764-772, 2003.

R. Dallel,

, Med Sci, vol.19, issue.5, pp.567-74, 2003.

, The International Classification of Headache Disorders, vol.24, pp.9-160, 2004.

A. Woda, Towards a new taxonomy of idiopathic orofacial pain, Pain, vol.116, issue.3, pp.396-406, 2005.

P. Goadsby and R. Lipton, International Headache Society Classification of trigeminal autonomic cephalgias (TACs), 1999.

G. Bauherz,

, Rev Med Brux, vol.21, issue.4, pp.207-220, 2000.

B. Colombo, P. O. Annovazzi, and G. Comi, Neuropathic cranial pain, Neurol Sci, vol.24, issue.2, pp.132-139, 2003.

M. Bergouignan, Cures heureuses de névralgies faciales essentielles par le diphenylhydantoinate de soude, Rev Laryngol Oto Rhinol, vol.63, pp.34-41, 1942.

T. Murphy, Psychoactive drugs for pain control, Pain Reviews, vol.1, pp.9-14, 1994.

G. Magni, Modifications of [3H]imipramine binding sites in platelets of chronic pain patients treated with mianserin, Pain, vol.30, issue.3, pp.311-331, 1987.

H. K. Manji, W. C. Drevets, and D. S. Charney, The cellular neurobiology of depression, Nat Med, vol.7, issue.5, pp.541-548, 2001.

J. J. Schildkraut, The catecholamine hypothesis of affective disorders: a review of supporting evidence, J Neuropsychiatry Clin Neurosci, vol.7, issue.4, pp.524-557, 1965.

W. E. Bunney, J. M. Jr, and . Davis, Norepinephrine in depressive reactions. A review, vol.13, pp.483-94, 1965.

E. J. Nestler and W. A. Carlezon, The mesolimbic dopamine reward circuit in depression, Biol Psychiatry, vol.59, issue.12, pp.1151-1160, 2006.

D. J. Nutt, Consensus statement and research needs: the role of dopamine and norepinephrine in depression and antidepressant treatment, J Clin Psychiatry, vol.67, pp.46-55, 2006.

D. Ardid, Involvement of bulbospinal pathways in the antinociceptive effect of clomipramine in the rat, Brain Res, vol.695, issue.2, pp.253-259, 1995.

C. A. Pettengill and L. Reisner-keller, The use of tricyclic antidepressants for the control of chronic orofacial pain, Cranio, vol.15, issue.1, pp.53-59, 1997.

M. C. De-felipe, Chronic antidepressant treatment increases enkephalin levels in n. accumbens and striatum of the rat, Eur J Pharmacol, vol.112, issue.1, pp.119-141, 1985.

A. M. Gray, P. S. Spencer, and R. D. Sewell, The involvement of the opioidergic system in the antinociceptive mechanism of action of antidepressant compounds, Br J Pharmacol, vol.124, issue.4, pp.669-74, 1998.

J. Sawynok, M. J. Esser, and A. R. Reid, Antidepressants as analgesics: an overview of central and peripheral mechanisms of action, J Psychiatry Neurosci, vol.26, issue.1, pp.21-30, 2001.

P. Skolnick, Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression, Pharmacopsychiatry, vol.29, issue.1, pp.23-29, 1996.

Z. Cai and P. P. Mccaslin, Amitriptyline, desipramine, cyproheptadine and carbamazepine, in concentrations used therapeutically, reduce kainate-and N-methyl-D-aspartate-induced intracellular Ca2+ levels in neuronal culture, Eur J Pharmacol, vol.219, issue.1, pp.53-60, 1992.

A. B. Malmberg and T. L. Yaksh, Voltage-sensitive calcium channels in spinal nociceptive processing: blockade of N-and P-type channels inhibits formalin-induced nociception, J Neurosci, vol.14, issue.8, pp.4882-90, 1994.

X. Y. Hua, The antinociceptive effects of spinally administered neuropeptide Y in the rat: systematic studies on structure-activity relationship, J Pharmacol Exp Ther, vol.258, issue.1, pp.243-251, 1991.

C. Stein, The control of pain in peripheral tissue by opioids, N Engl J Med, vol.332, issue.25, pp.1685-90, 1995.

X. Su and G. F. Gebhart, Effects of tricyclic antidepressants on mechanosensitive pelvic nerve afferent fibers innervating the rat colon, Pain, vol.76, issue.1-2, pp.105-119, 1998.

J. Sawynok, A. R. Reid, and M. J. Esser, Peripheral antinociceptive action of amitriptyline in the rat formalin test: involvement of adenosine, Pain, vol.80, issue.1-2, pp.45-55, 1999.

C. Keele and D. Armstrong, Substances producing pain and itch, 1964.

E. M. Davidson, R. E. Coggeshall, and S. M. Carlton, Peripheral NMDA and non-NMDA glutamate receptors contribute to nociceptive behaviors in the rat formalin test, Neuroreport, vol.8, issue.4, pp.941-947, 1997.

E. M. Davidson and S. M. Carlton, Intraplantar injection of dextrorphan, ketamine or memantine attenuates formalin-induced behaviors, Brain Res, vol.785, issue.1, pp.136-178, 1998.

P. D. Zaremba, Non-epilepsy uses of antiepilepsy drugs, Pharmacol Rep, vol.58, issue.1, pp.1-12, 2006.

E. Beghi, The use of anticonvulsants in neurological conditions other than epilepsy, CNS Drugs, vol.11, pp.61-82, 1999.

A. H. Dickenson, E. A. Matthews, and R. Suzuki, Neurobiology of neuropathic pain: mode of action of anticonvulsants, Eur J Pain, issue.6, pp.51-60, 2002.

R. Suzuki and A. H. Dickenson, Neuropathic pain: nerves bursting with excitement, Neuroreport, vol.11, issue.12, pp.17-21, 2000.

M. Devor, P. D. Wall, and N. Catalan, Systemic lidocaine silences ectopic neuroma and DRG discharge without blocking nerve conduction, Pain, vol.48, issue.2, pp.261-269, 1992.

S. H. Sindrup and T. S. Jensen, Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action, Pain, vol.83, issue.3, pp.389-400, 1999.

S. G. Waxman, The molecular pathophysiology of pain: abnormal expression of sodium channel genes and its contributions to hyperexcitability of primary sensory neurons, Pain, vol.6, pp.133-173, 1999.

S. D. Dib-hajj, Plasticity of sodium channel expression in DRG neurons in the chronic constriction injury model of neuropathic pain, Pain, vol.83, issue.3, pp.591-600, 1999.

K. Coward, Immunolocalization of SNS/PN3 and NaN/SNS2 sodium channels in human pain states, Pain, vol.85, issue.1-2, pp.41-50, 2000.

F. Porreca, A comparison of the potential role of the tetrodotoxin-insensitive sodium channels, PN3/SNS and NaN/SNS2, in rat models of chronic pain, Proc Natl Acad Sci, vol.96, issue.14, pp.7640-7644, 1999.

H. Vanegas and H. Schaible, Effects of antagonists to high-threshold calcium channels upon spinal mechanisms of pain, hyperalgesia and allodynia, Pain, vol.85, issue.1-2, pp.9-18, 2000.

E. A. Matthews and A. H. Dickenson, Effects of spinally delivered N-and P-type voltage-dependent calcium channel antagonists on dorsal horn neuronal responses in a rat model of neuropathy, Pain, vol.92, issue.1-2, pp.235-281, 2001.

M. M. Backonja, Use of anticonvulsants for treatment of neuropathic pain, Neurology, vol.59, issue.5, pp.14-21, 2002.

B. S. Meldrum, Glutamate as a neurotransmitter in the brain: review of physiology and pathology, J Nutr, issue.130, pp.1007-1022, 2000.

Y. Daikhin and M. Yudkoff, Compartmentation of brain glutamate metabolism in neurons and glia, J Nutr, issue.130, pp.1026-1057, 2000.

D. G. Trist, Excitatory amino acid agonists and antagonists: pharmacology and therapeutic applications, Pharm Acta Helv, vol.74, issue.2-3, pp.221-230, 2000.

A. H. Dickenson, Spinal cord pharmacology of pain, Br J Anaesth, vol.75, issue.2, pp.193-200, 1995.

A. H. Dickenson, V. Chapman, and G. M. Green, The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord, Gen Pharmacol, vol.28, issue.5, pp.633-641, 1997.

R. Suzuki, The effect of ABT-702, a novel adenosine kinase inhibitor, on the responses of spinal neurones following carrageenan inflammation and peripheral nerve injury, Br J Pharmacol, vol.132, issue.7, pp.1615-1638, 2001.

K. J. Carpenter and A. H. Dickenson, Amino acids are still as exciting as ever, Curr Opin Pharmacol, vol.1, issue.1, pp.57-61, 2001.

V. K. Kontinen and A. H. Dickenson, Effects of midazolam in the spinal nerve ligation model of neuropathic pain in rats, Pain, vol.85, issue.3, pp.425-456, 2000.

R. Olson and . Gaba, Neuropsychopharmacology : The Fifth Generation of Progress, 2002.

W. Sieghart, Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes, Pharmacol Rev, vol.47, issue.2, pp.181-234, 1995.

J. M. Kent, S. J. Mathew, and J. M. Gorman, Molecular targets in the treatment of anxiety, Biol Psychiatry, vol.52, issue.10, pp.1008-1038, 2002.

E. Cherubini and F. Conti, Generating diversity at GABAergic synapses, Trends Neurosci, vol.24, issue.3, pp.155-62, 2001.

M. J. Millan, The neurobiology and control of anxious states, Prog Neurobiol, vol.70, issue.2, pp.83-244, 2003.

M. Nazar, The role of the hippocampus and 5-HT/GABA interaction in the central effects of benzodiazepine receptor ligands, J Neural Transm, vol.106, pp.369-81, 1999.

N. Hajos, Cell type-and synapse-specific variability in synaptic GABAA receptor occupancy, Eur J Neurosci, vol.12, issue.3, pp.810-818, 2000.

B. M. Stell and I. Mody, Receptors with different affinities mediate phasic and tonic GABA(A) conductances in hippocampal neurons, J Neurosci, vol.22, issue.10, p.223, 2002.

P. L. Dellemijn and H. L. Fields, Do benzodiazepines have a role in chronic pain management? Pain, vol.57, pp.137-52, 1994.

O. Nakanishi, Effects of midazolam on pain sensations in the face. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, vol.84, pp.11-16, 1997.

S. A. King and J. J. Strain, Benzodiazepine use by chronic pain patients, Clin J Pain, vol.6, issue.2, pp.143-150, 1990.

R. B. Patt, G. Proper, and S. Reddy, The neuroleptics as adjuvant analgesics, J Pain Symptom Manage, vol.9, issue.7, pp.446-53, 1994.

A. G. Shepherd, Dopamine receptor genes and migraine with and without aura: an association study, Headache, vol.42, issue.5, pp.346-51, 2002.

M. J. Millan, Descending control of pain, Prog Neurobiol, vol.66, issue.6, pp.355-474, 2002.

S. Schreiber, The atypical neuroleptics clozapine and olanzapine differ regarding their antinociceptive mechanisms and potency, Pharmacol Biochem Behav, vol.64, issue.1, pp.75-80, 1999.

H. C. Siow, W. B. Young, and S. D. Silberstein, Neuroleptics in headache. Headache, vol.45, pp.358-71, 2005.

S. N. Raja, Opioids versus antidepressants in postherpetic neuralgia : a randomized, vol.59, pp.1015-1021, 2002.

R. L. Carasso, S. Yehuda, and M. Streifler, Clomipramine and amitriptyline in the treatment of severe pain, Int J Neurosci, vol.9, issue.3, pp.191-195, 1979.

F. Campbell, J. Graham, and K. Zilkha, Clinical trial of carbazepine (Tegretol) in trigeminal neuralgia, J Neurol Neurosurg Psychiatry, vol.29, pp.265-272, 1966.

J. M. Killian and G. H. Fromm, Carbamazepine in the treatment of neuralgia. Use of side effects, Arch Neurol, vol.19, issue.2, pp.129-165, 1968.

C. F. Nicol, A four year double-blind study of tegretol in facial pain. Headache, vol.9, pp.54-61, 1969.

B. W. Rockliff and E. H. Davis, Controlled sequential trials of carbamazepine in trigeminal neuralgia, Arch Neurol, vol.15, issue.2, pp.129-165, 1966.

J. Sato, Diagnostic significance of carbamazepine and trigger zones in trigeminal neuralgia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, vol.97, pp.18-22, 2004.

S. T. Vilming, T. Lyberg, and X. Lataste, Tizanidine in the management of trigeminal neuralgia, Cephalalgia, vol.6, issue.3, pp.181-183, 1986.

F. Lechin, Pimozide therapy for trigeminal neuralgia, Arch Neurol, vol.46, issue.9, pp.960-963, 1989.

P. Lindstrom and U. Lindblom, The analgesic effect of tocainide in trigeminal neuralgia, Pain, vol.28, issue.1, pp.45-50, 1987.

S. Parekh, Baclofen in carbamazepine resistant trigeminal neuralgia -A double blind clinical trial Cephalalgia, pp.392-395, 1989.

J. M. Zakrzewska, Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial, Pain, vol.73, issue.2, pp.223-253, 1997.

V. Delvaux and J. Schoenen, New generation anti-epileptics for facial pain and headache, Acta Neurol Belg, vol.101, issue.1, pp.42-48, 2001.

W. P. Cheshire and . Jr, Defining the role for gabapentin in the treatment of trigeminal neuralgia: a retrospective study, J Pain, vol.3, issue.2, pp.137-179, 2002.

C. Solaro, Topiramate relieves idiopathic and symptomatic trigeminal neuralgia, J Pain Symptom Manage, vol.21, issue.5, pp.367-375, 2001.

J. B. Peiris, Sodium valproate in trigeminal neuralgia, Med J Aust, vol.2, issue.5, p.278, 1980.

G. Lunardi, Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia, Neurology, vol.48, issue.6, pp.1714-1721, 1997.

I. Gilron, Topiramate in trigeminal neuralgia: a randomized, placebocontrolled multiple crossover pilot study, Clin Neuropharmacol, vol.24, issue.2, pp.109-121, 2001.

V. A. Filadora, T. C. Sist, and M. J. Lema, Acute herpetic neuralgia and postherpetic neuralgia in the head and neck: response to gabapentin in five cases, Reg Anesth Pain Med, vol.24, issue.2, pp.170-174, 1999.

O. A. Khan, Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients, Neurology, vol.51, issue.2, pp.611-615, 1998.

W. P. Cheshire, Felbamate relieved trigeminal neuralgia, Clin J Pain, vol.11, issue.2, pp.139-181, 1995.

J. M. Zakrzewska and P. N. Patsalos, Oxcarbazepine: a new drug in the management of intractable trigeminal neuralgia, J Neurol Neurosurg Psychiatry, vol.52, issue.4, pp.472-478, 1989.

V. Canavero and . Bonicalzi, Lamotrigine control of trigeminal neuralgia : an expanded study, J Neurol, vol.244, pp.527-532, 1997.

M. Leandri, Lamotrigine in trigeminal neuralgia secondary to multiple sclerosis, J Neurol, vol.247, pp.556-558, 2000.

. Borre, , 1997.

T. C. Sist, Gabapentin for idiopathic trigeminal neuralgia : report of two cases, Neurology, vol.48, pp.1467-1471, 1997.

M. Merren, Gabapentin for treatment of pain and tremor : a large case series, Southern Medical Journal, vol.91, pp.739-744, 1998.

F. Valzania, A. Strafella, and S. Nassetti, Gabapentin in idiopathic trigeminal neuralgia, Neurology, vol.50, 1998.

M. Haugh and G. Connor, Favourable response of trigeminal neuralgia to the anticonvulsant topiramate : a retrospective study, Cephalalgia, vol.20, issue.284, p.379, 2000.

M. R. Caccia, Clonazepam in facial neuralgia and cluster headache, Eur Neurol, vol.13, issue.6, pp.560-563, 1975.

J. E. Court and C. S. Kase, Treatment of tic douloureux with a new anticonvulsant (clonazepam), J Neurol Neurosurg Psychiatry, vol.39, issue.3, pp.297-306, 1976.

S. Smirne and G. Scarlato, Clonazepam in cranial neuralgias, Med J Aust, vol.1, issue.4, pp.93-97, 1977.

M. Swerdlow and J. G. Cundill, Anticonvulsant drugs used in the treatment of lancinating pain. A comparison, Anaesthesia, vol.36, issue.12, pp.1129-1161, 1981.

M. Swerdlow, Anticonvulsant drugs and chronic pain, Clin Neuropharmacol, vol.7, issue.1, pp.51-82, 1984.

G. Martin, The management of pain following laminectomy for lumbar disc lesions, Ann. R. Coll. Surg. Engl, vol.63, pp.244-252, 1981.

A. J. Bouckoms and R. E. Litman, Clonazepam in the treatment of neuralgic pain syndrome, Psychosomatics, vol.26, issue.12, pp.933-939, 1985.

S. Smirne and M. G. Sinatra, Riv Neurol, vol.49, issue.2, pp.140-50, 1979.

G. H. Fromm, C. F. Terrence, and A. S. Chattha, Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up, Ann Neurol, vol.15, issue.3, pp.240-244, 1984.

G. H. Fromm, Baclofen in trigeminal neuralgia: its effect on the spinal trigeminal nucleus: a pilot study, Arch Neurol, vol.37, issue.12, pp.768-71, 1980.

L. Steardo, A. Leo, and E. Marano, Efficacy of baclofen in trigeminal neuralgia and some other painful conditions. A clinical trial, Eur Neurol, vol.23, issue.1, pp.51-56, 1984.

B. S. Parmar, K. H. Shah, and I. C. Gandhi, Baclofen in trigeminal neuralgia--a clinical trial, Indian J Dent Res, vol.1, issue.4, pp.109-122, 1989.

G. H. Fromm, D. Aumentado, and C. F. Terrence, A clinical and experimental investigation of the effects of tizanidine in trigeminal neuralgia, Pain, vol.53, issue.3, pp.265-71, 1993.

I. Gilron, A randomized, controlled trial of high-dose dextromethorphan in facial neuralgias, Neurology, vol.55, issue.7, pp.964-71, 2000.

M. Volcy, Persistent idiopathic facial pain responsive to topiramate, Cephalalgia, vol.26, issue.4, pp.489-91, 2006.

C. Feinmann, M. Harris, and R. Cawley, Psychogenic facial pain: presentation and treatment, Br Med J (Clin Res Ed, vol.288, issue.6415, pp.436-444, 1984.

R. G. Lascelles, Atypical facial pain and depression, Br J Psychiatry, vol.112, issue.488, pp.651-660, 1966.

H. Forssell, Venlafaxine in the treatment of atypical facial pain: a randomized controlled trial, J Orofac Pain, vol.18, issue.2, pp.131-138, 2004.

S. D. Harrison, A comparison of antidepressant medication alone and in conjunction with cognitive behavioural therapy for chronic idiopathic facial pain, Proceedings of the 8th world congress on pain-Progress in pain research and management, vol.8, pp.663-72, 1997.

Y. Sharav, The analgesic effect of amitriptyline on chronic facial pain, Pain, vol.31, issue.2, pp.199-209, 1987.

N. Guler, E. Durmus, and S. Tuncer, Long-term follow-up of patients with atypical facial pain treated with amitriptyline, vol.71, pp.38-42, 2005.

S. D. Harrison, Atypical facial pain: a double-blind placebo-controlled crossover pilot study of subcutaneous sumatriptan, Eur Neuropsychopharmacol, vol.7, issue.2, pp.83-91, 1997.

T. Tammiala-salonen and H. Forssell, Trazodone in burning mouth pain: a placebocontrolled, double-blind study, J Orofac Pain, vol.13, issue.2, pp.83-91, 1999.

G. Maina, Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study, J Clin Psychiatry, vol.63, issue.1, pp.38-43, 2002.

F. Bogetto, Psychopharmacological treatment of burning mouth syndrom (BMS), Minerva Psichiatr, vol.40, pp.1-10, 1999.

D. Loldrup, Clomipramine and mianserin in chronic idiopathic pain syndrome. A placebo controlled study, Psychopharmacology (Berl), vol.99, issue.1, pp.1-7, 1989.

B. Van-houdenhove and P. Joostens, Burning mouth syndrome. Successful treatment with combined psychotherapy and psychopharmacotherapy, Gen Hosp Psychiatry, vol.17, issue.5, pp.385-393, 1995.

C. Gremeau-richard, Topical clonazepam in stomatodynia: a randomised placebo-controlled study, Pain, vol.108, issue.1-2, pp.51-58, 2004.

M. Grushka, J. Epstein, and A. Mott, An open-label, dose escalation pilot study of the effect of clonazepam in burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, vol.86, pp.557-61, 1998.

A. Woda, A possible therapeutic solution for stomatodynia (burning mouth syndrome), J Orofac Pain, vol.12, issue.4, pp.272-280, 1998.

J. B. Epstein, M. Grushka, and N. Le, Topical clonidine for orofacial pain: a pilot study, J Orofac Pain, vol.11, issue.4, pp.346-52, 1997.

S. M. Heckmann, Gabapentin has little or no effect in the treatment of burning mouth syndrome -results of an open-label pilot study, Eur J Neurol, vol.13, issue.7, pp.6-7, 2006.

H. S. White, Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs, Epilepsia, vol.40, pp.2-10, 1999.

C. M. Rizzatti-barbosa, Clinical evaluation of amitriptyline for the control of chronic pain caused by temporomandibular joint disorders, Cranio, vol.21, issue.3, pp.221-226, 2003.

O. Plesh, Amitriptyline treatment of chronic pain in patients with temporomandibular disorders, J Oral Rehabil, vol.27, issue.10, pp.834-875, 2000.

A. Toyofuku and H. Miyako, A case of temporo-mandibular disorder with fibromyalgia treated with the antidepressant, milnacipran, Hum Psychopharmacol, vol.19, issue.5, pp.357-365, 2004.

D. J. Denucci, C. Sobiski, and R. A. Dionne, Triazolam improves sleep but fails to alter pain in TMD patients, J Orofac Pain, vol.12, issue.2, pp.116-139, 1998.

E. Singer and R. Dionne, A controlled evaluation of ibuprofen and diazepam for chronic orofacial muscle pain, J Orofac Pain, vol.11, issue.2, pp.139-185, 1997.

C. M. Rizzatti-barbosa, Therapeutic response of benzodiazepine, orphenadrine citrate and occlusal splint association in TMD pain, Cranio, vol.21, issue.2, pp.116-136, 2003.

O. V. Roldan, Piroxicam, diazepam and placebo in the treatment of temporomandibular joint dysfunction. Double blind study, Rev Asoc Odontol Argent, vol.78, issue.2, pp.83-88, 1990.

S. Harkins, Administration of clonazepam in the treatment of TMD and associated myofascial pain: a double-blind pilot study, J Craniomandib Disord, vol.5, issue.3, pp.179-86, 1991.

C. R. Herman, The effectiveness of adding pharmacologic treatment with clonazepam or cyclobenzaprine to patient education and self-care for the treatment of jaw pain upon awakening: a randomized clinical trial, J Orofac Pain, vol.16, issue.1, pp.64-70, 2002.

L. Schwartz, Carisoprodol in the management of temporomandibular joint pain and dysfunction: a preliminary investigation, Ann N Y Acad Sci, vol.86, pp.245-254, 1960.

F. Gallardo, Carisoprodol in the treatment of myofascial pain-dysfunction syndrome, J Oral Surg, vol.33, issue.9, pp.655-663, 1975.

J. A. Gerschman, P. D. Reade, and G. D. Burrows, Evaluation of a proprietary analgesic/antihistamine in the management of pain associated with temporomandibular joint pain dysfunction syndrome, Aust Dent J, vol.29, issue.5, pp.300-304, 1984.

R. E. Kast, Tiagabine may reduce bruxism and associated temporomandibular joint pain, Anesth Prog, vol.52, issue.3, pp.102-106, 2005.

P. Kimos, Analgesic action of gabapentin on chronic pain in the masticatory muscles: a randomized controlled trial. Pain, vol.127, pp.151-60, 2007.

M. Ikawa, K. Yamada, and S. Ikeuchi, Efficacy of amitriptyline for treatment of somatoform pain disorder in the orofacial region: A case series, J Orofac Pain, vol.20, issue.3, pp.234-274, 2006.

I. J. Russell, Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam. A double-blind, placebo-controlled study, Arthritis Rheum, vol.34, issue.5, pp.552-60, 1991.

A. J. Raigrodski, S. E. Mohamed, and D. M. Gardiner, The effect of amitriptyline on pain intensity and perception of stress in bruxers, J Prosthodont, vol.10, issue.2, pp.73-80, 2001.

H. J. Mcquay, A systematic review of antidepressants in neuropathic pain, Pain, vol.68, issue.2-3, pp.217-244, 1996.

S. L. Collins, Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review, J Pain Symptom Manage, vol.20, issue.6, pp.449-58, 2000.

J. A. Mico, Antidepressants and pain, Trends Pharmacol Sci, vol.27, issue.7, pp.348-54, 2006.

P. Onghena and B. Van-houdenhove, Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies, Pain, vol.49, issue.2, pp.205-224, 1992.

M. B. Max, Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood, Neurology, vol.37, issue.4, pp.589-96, 1987.

A. Hrobjartsson and P. C. Gotzsche, Placebo interventions for all clinical conditions, Cochrane Database Syst Rev, issue.3, p.3974, 2004.

P. J. Wiffen, H. J. Mcquay, and R. A. Moore, Carbamazepine for acute and chronic pain, Cochrane Database Syst Rev, issue.3, p.5451, 2005.

J. C. Taylor, S. Brauer, and M. L. Espir, Long-term treatment of trigeminal neuralgia with carbamazepine, Postgrad Med J, vol.57, issue.663, pp.16-24, 1981.

N. Attal, EFNS guidelines on pharmacological treatment of neuropathic pain, Eur J Neurol, vol.13, issue.11, pp.1153-69, 2006.

P. J. Wiffen, Gabapentin for acute and chronic pain, Cochrane Database Syst Rev, issue.3, p.5452, 2005.

N. Attal, Pharmacologic treatment of neuropathic pain, Acta Neurol Belg, vol.101, issue.1, pp.53-64, 2001.

T. Saarto and P. J. Wiffen, Antidepressants for neuropathic pain, Cochrane Database Syst Rev, issue.3, p.5454, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00557402

M. K. Kreisberg, Tricyclic antidepressants: analgesic effect and indications in orofacial pain, J Craniomandib Disord, vol.2, issue.4, pp.171-178, 1988.

J. A. Lipton, J. A. Ship, and D. Larach-robinson, Estimated prevalence and distribution of reported orofacial pain in the United States, J Am Dent Assoc, vol.124, issue.10, pp.115-136, 1993.

I. Eli, Detection of psychopathologic trends in glossodynia patients, Psychosom Med, vol.56, issue.5, pp.389-94, 1994.

G. Davidoff, Trazodone hydrochloride in the treatment of dysesthetic pain in traumatic myelopathy: a randomized, double-blind, placebo-controlled study, Pain, vol.29, issue.2, pp.151-61, 1987.

K. Goodkin, C. M. Gullion, and W. S. Agras, A randomized, double-blind, placebocontrolled trial of trazodone hydrochloride in chronic low back pain syndrome, J Clin Psychopharmacol, vol.10, issue.4, pp.269-78, 1990.

P. Juni, The hazards of scoring the quality of clinical trials for meta-analysis, Jama, vol.282, issue.11, pp.1054-60, 1999.

J. M. Zakrzewska, H. Forssell, and A. M. Glenny, Interventions for the treatment of burning mouth syndrome: a systematic review, J Orofac Pain, vol.17, issue.4, pp.293-300, 2003.

R. A. Dionne, Pharmacologic treatments for temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, vol.83, pp.134-176, 1997.

L. E. White, Placebo : Theory, Research and Mechanisms, 1985.

F. Evans, The placebo in pain reduction, Advances in Neurologie, vol.4, 1974.

L. Reisner and C. A. Pettengill, The use of anticonvulsants in orofacial pain. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, vol.91, pp.2-7, 2001.

B. Colombo, P. O. Annovazzi, and G. Comi, Medications for neuropathic pain: current trends, Neurol Sci, vol.27, issue.2, pp.183-192, 2006.

L. B. Morgenstern, Headache in the emergency department, Headache, vol.41, issue.6, pp.537-578, 2001.

T. Kuntzer and I. Decosterd,

, Rev Med Suisse, vol.1, issue.43, pp.2812-2818, 2005.